naltrexone has been researched along with nandrolone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlin, G; Artursson, P; Bergström, CA; Gustavsson, L; Karlsson, J; Larsson, R; Matsson, P; Norinder, U; Pedersen, JM | 1 |
| Castaño-Duque, CH; Dávalos, A; Dorado-Bouix, L; García-Esperón, C; Gomis-Cortina, M; Hervás-García, JV; Jiménez-González, M; López-Cancio Martinez, E; Millán-Torné, M; Pérez de la Ossa-Herrero, N | 1 |
1 review(s) available for naltrexone and nandrolone
| Article | Year |
|---|---|
[Ingestion of anabolic steroids and ischaemic stroke. A clinical case report and review of the literature].
Topics: Adult; Alcoholism; Anabolic Agents; Brain Ischemia; Cerebral Angiography; Clenbuterol; Doping in Sports; Fibrinolytic Agents; Humans; Infarction, Middle Cerebral Artery; Male; Martial Arts; Mechanical Thrombolysis; Naltrexone; Nandrolone; Nandrolone Decanoate; Stanozolol; Steroids; Substance-Related Disorders; Testosterone Propionate; Tissue Plasminogen Activator; Tomography, X-Ray Computed | 2013 |
1 other study(ies) available for naltrexone and nandrolone
| Article | Year |
|---|---|
Structural requirements for drug inhibition of the liver specific human organic cation transport protein 1.
Topics: Cell Line; Computer Simulation; Drug Design; Gene Expression Profiling; Humans; Hydrogen Bonding; Liver; Molecular Weight; Organic Cation Transporter 1; Pharmaceutical Preparations; Predictive Value of Tests; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Structure-Activity Relationship | 2008 |